← Leaderboards
J. Sanford Schwartz
University Of Pennsylvania
$5,113,023
Attributed
$5,135,591
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $452.4K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,086,474 · 5
AHRQ$49,117 · 1
By mechanism
T32$2,539,861 · 1
U54$1,350,647 · 1
R01$1,150,830 · 1
R13$49,117 · 1
P20$45,136 · 1
P01$0 · 1
Top collaborators
- Joseph Nicholas Cappella1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Robert C. Hornik$22,077,886
- Meeta Prasad Kerlin$7,465,795
- David J. Margolis$22,280,628
- Lewis A Chodosh$38,386,361
- Ann E Rogers$1,312,769
Others in their field
Top investigators on “Training”
- Jeffrey P Krischer · University Of South Florida$314,856,919
- Christopher McKay · Battelle Memorial Institute$290,340,771
- Judith S. Currier · University Of California Los Angeles$276,624,848
- Daniel R Kuritzkes · Brigham And Women'S Hospital$258,658,543
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$239,830,683
- Steven E Reis · University Of Pittsburgh At Pittsburgh$232,330,444
Research focus
TrainingQuality Of LifeCost EffectivenessResearch PersonnelClinical ResearchHuman SubjectComorbidityControl GroupsCost Of IllnessAffectAfrican AmericanAdverse EventCancer TherapyBehavior TherapyAntibiotic TherapyCostBreast Cancer DiagnosisCellulitisCharacteristicsChronicChronic PainClinical EpidemiologyCohortAmbulatory Care
Grant awards (24)
Breast Cancer Related Lymphedema: Cost of Illness and Cost Effectiveness of Alt$253,081
U54 · FY2015 · CA · contact PI
Breast Cancer Related Lymphedema: Cost of Illness and Cost Effectiveness of Alt$226,661
U54 · FY2014 · CA · contact PI
Breast Cancer Related Lymphedema: Cost of Illness and Cost Effectiveness of Alt$248,739
U54 · FY2013 · CA · contact PI
Breast Cancer Related Lymphedema: Cost of Illness and Cost Effectiveness of Alt$258,040
U54 · FY2012 · CA · contact PI
Breast Cancer Related Lymphedema: Cost of Illness and Cost Effectiveness of Alt$364,126
U54 · FY2011 · CA · contact PI
Clinical epidemiology training in gastroenterology$76,309
T32 · FY2008 · DK · contact PI
Support of the 30th Annual Meeting of the Society for Medical Decision Making$49,117
R13 · FY2008 · HS · contact PI
Training / Career Development$45,136
P20 · FY2008 · CA · contact PI
Clinical epidemiology training in gastroenterology$296,268
T32 · FY2007 · DK · contact PI
Clinical epidemiology training in gastroenterology$79,259
T32 · FY2007 · DK · contact PI
Clinical epidemiology training in gastroenterology$76,900
T32 · FY2007 · DK · contact PI
Clinical Epidemiology Training in Gastroenterology$336,041
T32 · FY2006 · DK · contact PI
Clinical Epidemiology Training in Gastroenterology$74,171
T32 · FY2006 · DK · contact PI
Clinical Epidemiology Training in Gastroenterology$268,949
T32 · FY2005 · DK
Clinical Epidemiology Training in Gastroenterology$325,310
T32 · FY2004 · DK
Clinical Epidemiology Training in Gastroenterology$339,390
T32 · FY2003 · DK
PHYSICIAN-NURSE MANAGEMENT OF ELDERS WITH HEART FAILURE$385,067
R01 · FY2002 · NR
Clinical Epidemiology Training in Gastroenterology$335,604
T32 · FY2002 · DK
CLINICAL AND COST EFFECTIVENESS MODELING$0
P01 · FY2002 · CA
PHYSICIAN-NURSE MANAGEMENT OF ELDERS WITH HEART FAILURE$383,580
R01 · FY2001 · NR
CLINICAL EPIDEMIOLOGY TRAINING IN GASTROENTEROLOGY$189,333
T32 · FY2001 · DK
CLINICAL AND COST EFFECTIVENESS MODELING$0
P01 · FY2001 · CA
PHYSICIAN-NURSE MANAGEMENT OF ELDERS WITH HEART FAILURE$382,183
R01 · FY2000 · NR
CLINICAL EPIDEMIOLOGY TRAINING IN GASTROENTEROLOGY$142,327
T32 · FY2000 · DK